Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBos Glb Hldgs Regulatory News (BOS)

  • There is currently no data for BOS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Suspension of trading - Replacement

21 Dec 2017 08:40

RNS Number : 0460A
BOS GLOBAL Holdings Limited
21 December 2017
 

BOS GLOBAL Holdings Limited

ACN 009 087 852

 

AIM Release

21 December 2017

 

Suspension of trading - Replacement

 

This announcement replaces the "Suspension of trading" announcement released at 7:54am today with RNS number 0432A.

 

The announcement erroneously omitted the last sentence in the third paragraph. The full amended text of the announcement appears below and all other information remains unchanged.

 

* * * *

 

Further to the announcement dated 18 December 2017, BOS GLOBAL Holdings Limited ("BOS GLOBAL" or the "Company") provides the following update.

 

After an unsuccessful attempt, involving Innovation Corporation Limited ("Innovation"), historically the Company's primary funding provider, to complete a private placing on 1 December 2018, the Directors had been pursuing an approach from an alternative funding group. Discussions with the alternative funding partner have now ceased without any funding being provided to the Company.

 

A further offer was received late in the afternoon on 19 December 2017 from a group of shareholders (the "Group") comprising Graeme Edgar Hopgood, Scorus Capital Pty Ltd, Scorus Capital Innovations Pty Ltd, William Nicholas Giles, DJ Family Group Pty Ltd, Innovation Corporation Limited, Travia Superannuation Pty Ltd and National Accounts Pty Ltd ATF Bluerock Ventures Trust ("the Proposal"). The Board has sought further details as it considers that the Proposal is incomplete and does not contain sufficient detail to be fully assessed and contains conditions on external parties who may be unwilling or unable to provide these undertakings or assurances. The contents of the Proposal, including the quantum of funding being proposed, are however of sufficient interest such that the Company is urgently working with the Group in an effort to produce a more fully formed offer that may enable the Company to continue as a going concern for the benefit of shareholders, creditors and other stakeholders. With the cessation of discussions with the alternative funding partner, and in the absence of the Proposal, the Directors believed that only remaining option for the Company was voluntary administration, and thus the Proposal is seen as an alternative route worth pursuing.

 

Mr. Adam Webb and Mr. David Ireland, the two directors who are subject to re-election at the AGM scheduled to be held tomorrow, have now indicated their intention to resign as directors prior to the meeting. Should this occur, the ability for the sole remaining Director, Mr Mark Uren, to act are significantly restricted pursuant to the Company's constitution, which states that if the number of Directors is below the minimum fixed by the constitution, being a total of three (3), the Directors must not act except in emergencies, for appointing one or more Directors in order to make up a quorum for a meeting of Directors, or to call and arrange to hold a meeting of Members. Mr Uren is expected to be appointed Chairman in anticipation of the resignations tomorrow. The Company is seeking replacement directors, who are likely to be put forward by the Group.

 

The AGM will proceed at 10:30am (EDST Australia) tomorrow, although both resolutions contained in the Notice of Meeting (for the re-election of Adam Webb as a director of the Company and for the re-election of David Ireland as a director of the Company) will be withdrawn upon the resignation of Mr Webb and Mr Ireland.

 

With the uncertainty regarding its financial position and board composition, the Company considers that there is a significant risk that it would not be able to complete the audit process in time to meet the requirement of AIM Rule 19 for publication of the Accounts by 29 December 2017.

 

The requirement of AIM Rule 19 is that annual accounts must be published not later than six months after the end of the accounting period to which they relate. Publication of the Accounts after 29 December 2017 would result in the suspension of trading in the Company's shares on AIM until at least the date that the Accounts have been published.

 

The Company has therefore requested that trading in the Company's securities on AIM is suspended immediately pending clarification of the Company's financial position, its Board composition and the publication of its annual accounts.

 

This announcement contains inside information for the purpose of Article 7 of the Market Abuse

Regulation (EU) No. 596/2014. 

 

**ENDS**

 

For further information please visit www.bosglobal.com or contact:

Mark Uren

Executive Director

 

BOS GLOBAL Holdings Limited

Tel: +61 (0)8 9322 4071

 

Andrew Thomson

NOMAD

RFC Ambrian Limited

Tel: +61 (0) 8 9480 2500

Charles Goodfellow /

Lucy Williams

Broker

Peterhouse Corporate Finance Limited

Tel: +44 (0) 20 7220 9791

Charlotte Page / Hugo de Salis

Financial PR

St Brides Partners Ltd

Tel: +44 (0) 20 7236 1177

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFVTFDLLFID
Date   Source Headline
1st Jun 20067:02 amRNSOffer Update
31st May 20064:28 pmRNSDirector Declaration
31st May 200612:07 pmRNSEPT Disclosure
30th May 200611:18 amRNSEPT Disclosure
26th May 200612:00 pmRNSEPT Disclosure
26th May 200610:46 amRNSRule 8.3-Body Shop Intnl. PLC
25th May 200611:37 amRNSEPT Disclosure
25th May 200610:27 amRNSRule 8.3- Body Shop Intnl
24th May 200612:03 pmRNSEPT Disclosure
24th May 20069:43 amRNSRule 8.3-Body Shop Intnl. PLC
23rd May 20064:05 pmRNSRule 8.3- Body Shop Intnl.PLC
23rd May 20061:00 pmRNSEPT Disclosure
22nd May 200610:57 amRNSEPT Disclosure
19th May 200612:26 pmRNSEPT Disclosure - Replacement
19th May 200611:56 amRNSEPT Disclosure
19th May 200611:18 amRNSRule 8.3- Body Shop Intnl PLC
18th May 200611:35 amRNSEPT Disclosure
18th May 200611:34 amRNSRule 8.3- Body Shop Intnl.PLC
18th May 200610:03 amRNSRule 2.10 Announcement
18th May 20067:00 amRNSInvestor Presentation
17th May 200611:34 amRNSEPT Disclosure
17th May 20069:35 amRNSRule 8.3- Body Shop Intnl PLC
16th May 200612:03 pmRNSEPT Disclosure - Replacement
16th May 200611:13 amRNSEPT Disclosure
16th May 200610:23 amRNSRule 8.3- Body Shop Intnl PLC
15th May 200611:20 amRNSEPT Disclosure
15th May 20069:09 amRNSRule 8.3- Body Shop Intnl PLC
15th May 20068:47 amRNSStmnt re Share Price Movement
12th May 200611:48 amRNSDirector/PDMR Shareholding
12th May 200611:46 amRNSDirector/PDMR Shareholding
12th May 200611:04 amRNSEPT Disclosure
12th May 20068:31 amRNSRule 2.10 Announcement
11th May 200611:07 amRNSEPT Disclosure
11th May 20069:41 amRNSRule 8.3- Body Shop Intnl PLC
10th May 200611:14 amRNSEPT Disclosure
9th May 200611:45 amRNSEPT Disclosure - Replacement
9th May 200611:02 amRNSRule 8.3- Body Shop-Amendment
9th May 200610:45 amRNSRule 8.3- Body Shop Intnl.PLC
8th May 20065:43 pmRNSRule 8.3- Body Shop Intern'l
8th May 200612:07 pmRNSEPT Disclosure
5th May 200611:18 amRNSEPT Disclosure
5th May 20067:00 amRNSPreliminary Results
4th May 200611:43 amRNSEPT Disclosure
4th May 200610:34 amRNSRule 8.3-Body Shop Intnl. PLC
4th May 20067:01 amRNSOffer Update
3rd May 20065:28 pmRNSHolding(s) in Company
3rd May 20069:12 amRNSHolding(s) in Company
2nd May 200612:12 pmRNSEPT Disclosure
28th Apr 200611:39 amRNSEPT Disclosure
27th Apr 200611:44 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.